Neoadjuvant enoblituzumab in localized prostate cancer: a single-arm, phase 2 trial
Eugene Shenderov, Angelo M. De Marzo, Tamara L. Lotan, Hao Wang, Sin Chan, Su Jin Lim, Hongkai Ji, Mohamad E. Allaf, Carolyn G. Chapman, Paul A. Moore, Francine Chen, Kristina Sorg, Andrew White, S. Church, Briana M. Hudson, Paul Fields, Shaohui Hu, Samuel R. Denmeade, Kenneth J. Pienta, Christian P. Pavlovich, Ashley E. Ross, Charles G. Drake, Drew M. Pardoll, Emmanuel S. Antonarakis
Topics & Concepts
Prostate cancerOncologyMedicineProstateInternal medicineNeoadjuvant therapyUrologyCancerBreast cancerProstate Cancer Treatment and ResearchCancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses